| Literature DB >> 29943281 |
Jiaxiang Zhang1, Anh Q Vo1, Xin Feng1, Suresh Bandari1, Michael A Repka2,3.
Abstract
Inter-individual variability is always an issue when treating patients of different races, genders, ages, pharmacogenetics, and pharmacokinetic characteristics. However, the development of novel dosage forms is limited by the huge investments required for production line modifications and dosages diversity. Additive manufacturing (AM) or 3D printing can be a novel alternative solution for the development of controlled release dosages because it can produce personalized or unique dosage forms and more complex drug-release profiles. The primary objective of this manuscript is to review the 3D printing processes that have been used in the pharmaceutical area, including their general aspects, materials, and the operation of each AM technique. Advantages and shortcomings of the technologies are discussed with respect to practice and practical applications. Thus, this review will provide an overview and discussion on advanced pharmaceutical AM technologies, which can be used to produce unique controlled drug delivery systems and personalized dosages for the future of personalized medicine.Entities:
Keywords: 3D printing; drug delivery system; patient-centered drug development; personalized dosages; pharmaceutical additive manufacturing
Mesh:
Substances:
Year: 2018 PMID: 29943281 PMCID: PMC6283689 DOI: 10.1208/s12249-018-1097-x
Source DB: PubMed Journal: AAPS PharmSciTech ISSN: 1530-9932 Impact factor: 3.246